Short answer · Medically reviewed summary · Last updated: 2026-04-07
MELAS syndrome, which stands for Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes, is the primary clinical term used by medical professionals. While it is occasionally referred to as mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes, the acronym MELAS syndrome remains the universal standard for diagnosis and clinical research. What are the formal and alternative names for MELAS syndrome? The clinical term MELAS syndrome is an acronym that describes the core features of the condition.
1 people with MELAS Syndrome have shared their first-person experience on this question at DiseaseMaps.
MELAS syndrome, which stands for Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes, is the primary clinical term used by medical professionals. While it is occasionally referred to as mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes, the acronym MELAS syndrome remains the universal standard for diagnosis and clinical research.
The clinical term MELAS syndrome is an acronym that describes the core features of the condition. In medical literature and patient records, you may occasionally encounter descriptive phrases rather than the acronym, such as “mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes.” Because this is a multisystemic disorder, older medical texts might sometimes categorize it under the broader umbrella of “mitochondrial cytopathy” or “mitochondrial myopathy,” though these terms are less specific than MELAS syndrome and are rarely used as formal diagnostic labels today.
The naming of MELAS syndrome reflects its historical identification as a clinical syndrome rather than a single genetic mutation. When the condition was first characterized in the 1980s, physicians grouped patients based on their shared presentation: brain involvement (encephalopathy), muscle weakness (myopathy), metabolic imbalance (lactic acidosis), and neurological events resembling strokes. As genetic testing advanced, we learned that MELAS syndrome is most commonly caused by specific mutations in mitochondrial DNA (such as m.3243A>G). Because the syndrome can present with varying levels of severity and different organ involvement, some clinicians historically used descriptive names before the standard acronym became globally accepted.
To ensure consistency across international healthcare systems, researchers and clinicians use standardized databases. If you are searching for records or clinical trials, you will find MELAS syndrome consistently indexed under the following identifiers:
When communicating with your healthcare team, it is best to use the term MELAS syndrome. This is the term recognized by the 80 members within the DiseaseMaps.org community and is the standard entry point for genetic counseling and specialist referrals. Using the acronym ensures that your medical records are easily searchable for specialists in neurology and metabolic genetics, who will immediately recognize the specific diagnostic criteria associated with the condition.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.